CNC earnings analysis
What we found in CNC's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Centene delivered a strong year-over-year recovery in Q2 2026: revenue increased 10% to $53.579 billion, GAAP EPS improved to $2.19 from a $(0.51) loss, and operating income reached $1.198 billion versus a $458 million loss. Margin improvement was driven by Marketplace pricing and risk-adjustment benefits, Medicaid rate and medical-cost management, and improved Medicare profitability, although EPS and operating margin moderated sequentially from Q1. Cash generation and leverage improved materially, but shrinking membership, the expected loss of approximately 250,000 California Medicaid members in 2027, and $315 million to $365 million of expected severance costs remain key offsets.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue growth accelerated to $53.6B
- Q2 total revenue was $53.579 billion, up 10% from $48.742 billion in Q2 2025. Sequentially, revenue increased from an implied $49.944 billion in Q1 2026, based on $103.523 billion of first-half revenue, or approximately 7%.
- EPS returned to profitability
- GAAP diluted EPS recovered to $2.19 from a $(0.51) loss in Q2 2025, a $2.70-per-share improvement. EPS declined sequentially from an implied $3.11 in Q1 2026, based on first-half EPS of $5.30.
- Operating margin sharply better year over year
- Operating income was $1.198 billion, versus a $458 million operating loss a year earlier; operating margin improved to 2.2% from negative 0.9%. The margin was lower than the implied 3.7% in Q1 2026, when operating income was $1.861 billion on $49.944 billion of revenue.
- Medical-cost improvement expanded margins
- Gross margin was $4.617 billion, or 10.4% of premium and service revenue, compared with $3.018 billion, or 7.1%, in Q2 2025. The 330-basis-point expansion reflected an HBR of 89.6%, down from 93.0%.
- Cash generation strengthened materially
- Operating cash flow was $7.956 billion in the first six months of 2026, up from $3.295 billion a year earlier. After $374 million of capital expenditures, implied first-half free cash flow was $7.582 billion and capex was 4.7% of operating cash flow.
- Working capital and leverage improved
- Liquidity and leverage improved: working capital rose to $5.9 billion from $3.7 billion at December 31, 2025, while debt-to-capital fell to 41.6% from 46.5% following $1.3 billion of senior-note repurchases.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Membership contraction remains substantial
- Managed-care membership fell 2.1 million, or 8%, year over year to 25.9 million. Commercial membership declined to 4.0 million from 6.3 million, including Marketplace membership falling to 3.5 million from 5.9 million.
- California transition threatens 250,000 members
- California's January 2027 transition of the Medi-Cal UIS population to fee-for-service is expected to affect approximately 250,000 Health Net members, reducing California Medicaid membership and associated premium revenue.
- Severance program creates near-term charges
- The company expects $315 million to $365 million of severance costs during the remainder of 2026 under its voluntary separation program, with possible additional 2027 enterprise-optimization charges not yet estimable.
- Part D receivables present cash-timing risk
- Centene has $2.7 billion of eligible 2025 Part D risk-sharing receivables still outstanding at June 30, 2026. It sold a $1.0 billion participating interest in March for $970 million of proceeds, incurring a $30 million pre-tax loss, illustrating timing and monetization risk around CMS payments.
- No formal risk-factor updates; rate exposure persists
- The filing states that there were no material changes to the risk factors in the 2025 Form 10-K. However, a hypothetical immediate 1% rate increase would reduce fixed-income investment fair value by approximately $618 million.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $2.19
- Gross margin
- 10.4%
- Operating margin
- 2.2%
- Segment
- Medicaid revenue: $31.970 billion, up 14% year over year; gross margin: $1.388 billion, up 24%.
- Segment
- Medicare revenue: $11.057 billion, up 17% year over year; gross margin: $1.165 billion, up 35%.
- Segment
- Commercial revenue: $9.356 billion, down 7% year over year; gross margin: $1.947 billion, up 106%.
- Segment
- Other revenue: $1.196 billion, down 2% year over year; gross margin: $117 million, up 27%.
What they said about what is next.
The 10-Q does not provide an updated quantitative revenue or EPS outlook. Management expects approximately $600 million of insurance-subsidiary dividends and approximately $400 million of additional capital expenditures during the remainder of 2026; it also estimates $315 million to $365 million of severance costs during the remainder of 2026.
The filing reads better than the one before it.
What came before.
- 10-Q · April 28, 2026
- Centene reported a strong Q1 2026: total revenues of $49,944 million (+7% YoY) and GAAP diluted EPS of $3.11 (+18% YoY). Medical cost trends remained elevated but margins ticked modestly better (HBR 87.3% vs 87.5%)…
- 10-K · February 17, 2026
- Centene reported full-year 2025 revenues of $194.8 billion and membership of 27.6 million, reflecting continued scale as the nation's largest Medicaid and Marketplace insurer. However, GAAP results were materially…
- 10-Q · July 25, 2025
- Centene reported strong top-line growth with total revenues of $48,742 million for Q2 2025, up $8,906 million versus Q2 2024 ($39,836 million), but profitability deteriorated: operating loss was $(458) million and GAAP…
- 10-Q · July 26, 2024
- Centene beat consensus in Q2 with revenues of $39,836 million (up $2,228 million or 5.9% vs Q2 2023) and GAAP diluted EPS of $2.16 (up $0.24 or 12.5% vs Q2 2023). Operating income was $1,229 million (operating margin…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CNC makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever